Back to News
Market Impact: 0.32
BioAffinity Technologies Stock Surges Following Hong Kong Patent Grant
Source: benzinga.com
Patents & Intellectual PropertyHealthcare & Biotech
BioAffinity Technologies shares surged Thursday after receiving a key Hong Kong patent for its CyPath Lung diagnostic, strengthening intellectual-property protection for the product. BioAffinity warrants rose nearly 20% late Thursday, reflecting a positive investor response to the patent catalyst.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
BIAF0.82
More News
- Halozyme prices $1.3 billion convertible notes offering
- Jana Partners pushes Cooper to replace CEO, weigh asset sales- WSJ
- FDA approves Ultragenyx’s Fayuvi for Sanfilippo syndrome Type A
- Why is Xenon Pharmaceuticals stock plunging today?
- Intel and Micron lead our portfolio higher, and J&J's strengthens our case for owning it
- Ultragenyx stock surges 10% on FDA approval for gene therapy